Paratek Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q1 2012 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Paratek Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2023.
  • Paratek Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2023 was 34.5 %, a 47.6% decline year-over-year.
  • Paratek Pharmaceuticals, Inc. annual Return On Equity for 2022 was 40.6 %, a 22.6% decline from 2021.
  • Paratek Pharmaceuticals, Inc. annual Return On Equity for 2021 was 52.4 %, a 59.2% decline from 2020.
  • Paratek Pharmaceuticals, Inc. annual Return On Equity for 2020 was 128 %, a 80.6% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 34.5 -31.3 -47.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 39 -10.7 -21.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 40.6 -11.8 -22.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 60.8 +12 +24.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 65.8 +11.4 +20.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 49.7 -46.1 -48.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 52.4 -76 -59.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 48.7 -117 -70.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 54.4 -168 -75.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 95.7 -228 -70.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 128 -533 -80.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 166 +5.49K Jul 1, 2020 Sep 30, 2020
Q2 2020 222 +682 Apr 1, 2020 Jun 30, 2020
Q1 2020 324 +557 Jan 1, 2020 Mar 31, 2020
Q4 2019 661 +810 Oct 1, 2019 Dec 31, 2019
Q3 2019 -5.33K -5.2K -3920% Jul 1, 2019 Sep 30, 2019
Q2 2019 -460 -354 -332% Apr 1, 2019 Jun 30, 2019
Q1 2019 -233 -145 -165% Jan 1, 2019 Mar 31, 2019
Q4 2018 -149 -55.5 -59.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -133 -31.2 -30.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -106 +1.63 +1.51% Apr 1, 2018 Jun 30, 2018
Q1 2018 -87.7 +36.3 +29.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -93.6 +39 +29.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -101 +14.8 +12.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -108 -2.22 -2.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -124 -40 -47.7% Jan 1, 2017 Mar 31, 2017
Q4 2016 -133 -69.3 -109% Oct 1, 2016 Dec 31, 2016
Q3 2016 -116 -60.9 -110% Jul 1, 2016 Sep 30, 2016
Q2 2016 -106 -60 -131% Apr 1, 2016 Jun 30, 2016
Q1 2016 -84 -41.5 -97.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -63.4 -33.7 -114% Oct 1, 2015 Dec 31, 2015
Q3 2015 -55.2 +102 +64.9% Jul 1, 2015 Sep 30, 2015
Q2 2015 -45.8 +29.1 +38.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -42.6 +22.7 +34.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -29.6 +56.3 +65.5% Oct 1, 2014 Dec 31, 2014
Q3 2014 -157 -68.9 -78.2% Jul 1, 2014 Sep 30, 2014
Q2 2014 -74.9 -25.8 -52.4% Apr 1, 2014 Jun 30, 2014
Q1 2014 -65.3 -24.3 -59.3% Jan 1, 2014 Mar 31, 2014
Q4 2013 -85.9 -52.9 -160% Oct 1, 2013 Dec 31, 2013
Q3 2013 -88.1 -87.9 -42891% Jul 1, 2013 Sep 30, 2013
Q2 2013 -49.1 -34.8 -244% Apr 1, 2013 Jun 30, 2013
Q1 2013 -41 -29.4 -254% Jan 1, 2013 Mar 31, 2013
Q4 2012 -33.1 Oct 1, 2012 Dec 31, 2012
Q3 2012 -0.2 Jul 1, 2012 Sep 30, 2012
Q2 2012 -14.3 Apr 1, 2012 Jun 30, 2012
Q1 2012 -11.6 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.